omega-n-methylarginine has been researched along with Coronary Artery Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltrame, JF; Carbone, A; Copus, B; Leong, DP; Liew, GY; Nelson, AJ; Nicholls, SJ; Puri, R; Wong, DT; Worthley, MI; Worthley, SG | 1 |
| Camici, PG; Gnecchi-Ruscone, T; Kaufmann, PA; Luscher, TF; Rimoldi, OE | 1 |
1 trial(s) available for omega-n-methylarginine and Coronary Artery Stenosis
| Article | Year |
|---|---|
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses.
Topics: Adenosine; Adult; Aged; Blood Pressure; Coronary Stenosis; Coronary Vessels; Enzyme Inhibitors; Female; Fractional Flow Reserve, Myocardial; Heart Rate; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Positron-Emission Tomography; Research Design; Severity of Illness Index; Vasodilation; Vasodilator Agents | 2007 |
1 other study(ies) available for omega-n-methylarginine and Coronary Artery Stenosis
| Article | Year |
|---|---|
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; omega-N-Methylarginine; Severity of Illness Index; Shear Strength; Ultrasonography, Doppler; Ultrasonography, Interventional; Vascular Remodeling; Vasodilation | 2015 |